Rafferty Asset Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $9.8M | Buy |
50,899
+10,167
| +25% | +$1.26M | 0.03% | 262 |
|
|
2026
Q2 | $4.19M | Sell |
40,732
-55,523
| -58% | -$3.61M | 0.01% | 400 |
|
|
2026
Q1 | $4.57M | Sell |
96,255
-18,003
| -16% | -$807K | 0.02% | 413 |
|
|
2025
Q4 | $3.62M | Sell |
114,258
-10
| -0% | -$312 | 0.01% | 518 |
|
|
2025
Q3 | $3.22M | Buy |
114,268
+38,608
| +51% | +$1.17M | 0.01% | 534 |
|
|
2025
Q2 | $2.78M | Sell |
75,660
-23,624
| -24% | -$816K | 0.01% | 529 |
|
|
2025
Q1 | $3.9M | Buy |
99,284
+5,965
| +6% | +$269K | 0.02% | 422 |
|
|
2024
Q4 | $4.34M | Sell |
93,319
-45,786
| -33% | -$2.07M | 0.02% | 444 |
|
|
2024
Q3 | $6.28M | Buy |
139,105
+36,028
| +35% | +$1.71M | 0.02% | 365 |
|
|
2024
Q2 | $5.08M | Sell |
103,077
-141,015
| -58% | -$5.75M | 0.02% | 410 |
|
|
2024
Q1 | $8.37M | Buy |
244,092
+14,483
| +6% | +$523K | 0.03% | 336 |
|
|
2023
Q4 | $8.46M | Sell |
229,609
-109,317
| -32% | -$2.53M | 0.04% | 325 |
|
|
2023
Q3 | $6.87M | Sell |
338,926
-74,745
| -18% | -$1.64M | 0.04% | 328 |
|
|
2023
Q2 | $8.46M | Sell |
413,671
-17,397
| -4% | -$261K | 0.05% | 248 |
|
|
2023
Q1 | $6.5M | Buy |
431,068
+100,718
| +30% | +$2.22M | 0.04% | 315 |
|
|
2022
Q4 | $7.87M | Buy |
330,350
+173,102
| +110% | +$5.02M | 0.07% | 269 |
|
|
2022
Q3 | $5.54M | Buy |
157,248
+14,618
| +10% | +$621K | 0.06% | 319 |
|
|
2022
Q2 | $4.99M | Buy |
142,630
+20,532
| +17% | +$727K | 0.05% | 277 |
|
|
2022
Q1 | $6.03M | Buy |
122,098
+58,645
| +92% | +$3.25M | 0.04% | 327 |
|
|
2021
Q4 | $4.91M | Buy |
63,453
+37,791
| +147% | +$3.88M | 0.03% | 393 |
|
|
2021
Q3 | $2.74M | Buy |
25,662
+2,907
| +13% | +$333K | 0.02% | 532 |
|
|
2021
Q2 | $3.03M | Sell |
22,755
-799
| -3% | -$92.9K | 0.02% | 497 |
|
|
2021
Q1 | $2.92M | Buy |
23,554
+16,973
| +258% | +$2.58M | 0.02% | 513 |
|
|
2020
Q4 | $930K | Sell |
6,581
-25,161
| -79% | -$2.79M | 0.01% | 525 |
|
|
2020
Q3 | $2.41M | Buy |
31,742
+14,113
| +80% | +$879K | 0.03% | 362 |
|
|
2020
Q2 | $799K | Buy |
+17,629
| New | +$633K | 0.01% | 605 |
|
|
2020
Q1 | – | Sell |
-23,258
| Closed | -$488K | – | 796 |
|
|
2019
Q4 | $488K | Sell |
23,258
-21,488
| -48% | -$503K | 0.01% | 691 |
|
|
2019
Q3 | $1.07M | Buy |
44,746
+22,117
| +98% | +$643K | 0.02% | 520 |
|
|
2019
Q2 | $656K | Buy |
+22,629
| New | +$599K | 0.01% | 637 |
|
Other funds holding TWST
Rafferty Asset Management's TWST Position: Q3 2026 in Review
Rafferty Asset Management increased its Twist Bioscience (TWST) stake by 25% in Q3 2026, buying an estimated $1.26M and bringing the position to 50,899 shares worth $9.8M. The position accounts for 0.03% of the portfolio, ranked #262.
Rafferty Asset Management first reported a position in TWST in Q2 2019 and has held it in 29 quarters since. 433 funds tracked by Wall St. Rank hold TWST as of Q3 2026.
- Rafferty Asset Management held 50,899 shares of Twist Bioscience worth $9.8M as of Q3 2026.
- Rafferty Asset Management bought 10,167 Twist Bioscience shares in Q3 2026, an estimated $1.26M.
- Twist Bioscience made up 0.03% of Rafferty Asset Management's portfolio in Q3 2026, its #262 holding.
- Rafferty Asset Management first reported a position in Twist Bioscience in Q2 2019 and has held it in 29 quarters since.
- 433 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.